Sinusitis caused by a rare organism, Cedecea lapagei.
BMJ Case Rep
; 13(7)2020 Jul 20.
Article
in English
| MEDLINE | ID: covidwho-657507
ABSTRACT
A 45-year-old man presented with acute sinusitis. He was treated with a 10-day course of trimethoprim/sulfamethoxazole, and a subsequent 14-day course of amoxicillin-clavulanate with no improvement in symptoms. Culture of purulent nasal secretions revealed the rare enterobacter Cedecea lapagei The patient had complete resolution of his symptoms after a 14-day course of gentamicin/dexamethasone nasal rinses. Emerging pathogens have been a timeless concern for physicians, as witnessed by the current SARS-CoV-2 outbreak. C. lapagei has been reported to cause human infection only a dozen times since its discovery, all in severely compromised patients. This is the first documented case of sinusitis reported with C. lapagei and may portend a rising prevalence of disease burden in the general population. This case demonstrates the necessity of obtaining cultures when standard antibiotics result in treatment failure.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Sinusitis
/
Dexamethasone
/
Gentamicins
/
Enterobacteriaceae Infections
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Year:
2020
Document Type:
Article
Affiliation country:
Bcr-2020-235331
Similar
MEDLINE
...
LILACS
LIS